Piper Sandler upgraded Colgate-Palmolive (CL) to Overweight from Neutral with a price target of $88, up from $82. While the company saw continued softness in Q4, this is priced into the shares and Colgate’s growth can accelerate in 2026, the analyst tells investors in a research note. Piper is seeing early signs of improvement for the company in emerging markets. Colgate-Palmolive’s valuation looks attractive if improvement is coming, contends Piper. The firm likes Colgate’s lower reliance on the “stretched U.S. given its exposure to emerging markets.
Claim 70% Off TipRanks Premium
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis and maximize your portfolio's potential
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on CL:
- Colgate-Palmolive upgraded to Overweight from Neutral at Piper Sandler
- The Week That Was, The Week Ahead: Macro and Markets, Jan. 4
- The Week That Was, The Week Ahead: Macro & Markets, Dec. 20
- Colgate-Palmolive price target raised to $90 from $88 at BofA
- Colgate-Palmolive price target raised to $88 from $87 at JPMorgan